We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
IB
1226
Intrust Bank
Kansas
$1.5M -$93.9K -2,985 -6%
LJHT
1227
Laurie J. Hall Trustee
$1.49M -$23.8K -757 -1%
CIM
1228
Cetera Investment Management
California
$1.49M +$1.53M +48,495 New
KFS
1229
Kurt F. Somerville
$1.48M
BAS
1230
Brown Advisory Securities
Maryland
$1.48M +$15.7K +498 +1%
NCM
1231
Neumann Capital Management
California
$1.47M -$16.6K -527 -1%
MCM
1232
Maple Capital Management
Vermont
$1.47M +$25.7K +818 +2%
SFM
1233
Signet Financial Management
New Jersey
$1.47M +$210K +6,668 +16%
Parallax Volatility Advisers
1234
Parallax Volatility Advisers
California
$1.46M -$5.48M -174,096 -78%
P
1235
Pitcairn
Pennsylvania
$1.45M +$60.9K +1,935 +4%
BAM
1236
Burnham Asset Management
New York
$1.45M -$63.8K -2,028 -4%
VFA
1237
Voya Financial Advisors
Connecticut
$1.45M +$165K +5,230 +13%
DMIC
1238
Dixon Mitchell Investment Counsel
British Columbia, Canada
$1.44M -$155K -4,927 -9%
CPIM
1239
Columbia Partners Investment Management
Virginia
$1.44M +$543K +17,268 +58%
EGA
1240
E&G Advisors
Texas
$1.44M
CHAM
1241
Clear Harbor Asset Management
Connecticut
$1.43M -$87.5K -2,780 -6%
CK
1242
Cohen Klingenstein
New York
$1.43M
WA
1243
Wheatland Advisors
Pennsylvania
$1.42M -$3.3K -105 -0.2%
BWP
1244
Baldwin Wealth Partners
Massachusetts
$1.41M -$94.8K -3,015 -6%
NERM
1245
New England Research & Management
Illinois
$1.41M -$53.1K -1,687 -4%
PWS
1246
Peloton Wealth Strategists
Indiana
$1.4M -$99.5K -3,162 -6%
MCM
1247
Mengis Capital Management
Oregon
$1.39M +$197K +6,277 +16%
CCM
1248
Canal Capital Management
Virginia
$1.38M +$24.4K +777 +2%
DAM
1249
Delta Asset Management
Tennessee
$1.38M +$32.2K +1,022 +2%
PAM
1250
Premier Asset Management
Illinois
$1.37M +$28.2K +896 +2%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.